Faculty, Staff and Student Publications
Language
English
Publication Date
11-1-2025
Journal
Blood Neoplasia
DOI
10.1016/j.bneo.2025.100153
PMID
41090157
PMCID
PMC12517091
PubMedCentral® Posted Date
8-4-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Deletions and translocations affecting WWOX accompanied by loss of expression are frequently observed in B-cell neoplasms and are linked to poor prognosis. Our previous research showed that Wwox deletion early in B-cell development induces genomic instability, neoplastic transformation, and monoclonal gammopathies in mice. In this study, by crossing Cd19 Wwox knockout (KO) with Vk∗MYC myeloma model mice, we generated a model with concurrent Wwox deletion and MYC activation, reproducing 2 common oncogenic alterations in B- and plasma-cell cancers. We observed that Vk∗MYC:Wwox KO mice exhibited significantly reduced survival rates primarily due to the development of plasmablastic plasmacytomas and lymphomas. Transcriptome profiling from bone marrow derived CD138+ plasma cells and plasmablastic tumors revealed enrichment of biofunctions related to tumorigenic phenotype and inflammation activation upon Wwox deletion in Vk∗MYC mice. Wwox KO plasmablastic tumors displayed mutations affecting classical cancer genes, DNA damage response (DDR) genes, as well as overexpression of Aid/Apobec family members associated to hypermutation and DDR mutational signatures. These findings illustrate the significant pathobiological effects of B-cell–specific Wwox deletion and support a relevant role for WWOX loss of function in B-cell neoplastic progression toward more aggressive phenotypes.
Published Open-Access
yes
Recommended Citation
Hussain, Tabish; Bramble, Matthew D; Liu, Bin; et al., "B-Cell-Specific Wwox Deletion Promotes Plasmablastic Tumor Development and Proinflammatory Signatures in Myeloma Model" (2025). Faculty, Staff and Student Publications. 5259.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5259
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons